EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H28N2O5 |
| Net Charge | 0 |
| Average Mass | 424.497 |
| Monoisotopic Mass | 424.19982 |
| SMILES | [H][C@]1(N[C@@H](CCc2ccccc2)C(=O)OCC)CCc2ccccc2N(CC(=O)O)C1=O |
| InChI | InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1 |
| InChIKey | XPCFTKFZXHTYIP-PMACEKPBSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1). |
| Applications: | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1). prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| benazepril (CHEBI:3011) has functional parent benazeprilat (CHEBI:88200) |
| benazepril (CHEBI:3011) has role EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor (CHEBI:35457) |
| benazepril (CHEBI:3011) has role prodrug (CHEBI:50266) |
| benazepril (CHEBI:3011) is a benzazepine (CHEBI:35676) |
| benazepril (CHEBI:3011) is a dicarboxylic acid monoester (CHEBI:36244) |
| benazepril (CHEBI:3011) is a ethyl ester (CHEBI:23990) |
| benazepril (CHEBI:3011) is a lactam (CHEBI:24995) |
| benazepril (CHEBI:3011) is conjugate base of benazepril(1+) (CHEBI:88201) |
| Incoming Relation(s) |
| benazepril(1+) (CHEBI:88201) is conjugate acid of benazepril (CHEBI:3011) |
| IUPAC Name |
|---|
| [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid |
| INNs | Source |
|---|---|
| bénazépril | WHO MedNet |
| benazepril | WHO MedNet |
| benazepril | WHO MedNet |
| benazeprilum | WHO MedNet |
| Synonyms | Source |
|---|---|
| Benazepril | KEGG COMPOUND |
| 1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(R*,R*))- | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| C06843 | KEGG COMPOUND |
| Benazepril | Wikipedia |
| DB00542 | DrugBank |
| D07499 | KEGG DRUG |
| HMDB0014682 | HMDB |
| CPD-15329 | MetaCyc |
| EP72352 | Patent |
| US4410520 | Patent |
| LSM-5609 | LINCS |
| 299 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:4302258 | Reaxys |
| CAS:86541-75-5 | KEGG COMPOUND |
| CAS:86541-75-5 | ChemIDplus |
| Citations |
|---|